Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-09

Clinical Trial Update: Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use)

View source ↗

Summary

Cannabidiol Expanded Access program for drug-resistant pediatric epilepsy is available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: John | Conditions: Drug Resistant Epilepsy | Status: AVAILABLE